PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
Key Details
Context & Analysis
National Institutes of Health posted this funding opportunity on June 30, 2026 (opportunity number RFA-RM-27-012). It is catalogued under CFDA number 93.310. Applications are accepted through October 19, 2026 — 89 days remaining.
Similar Grant Opportunities
Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial Optional)
National Institutes of Health
Single Source: Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VCID) in the United States (U19 - Clinical Trial Not Allowed)
National Institutes of Health
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)
National Institutes of Health
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
National Institutes of Health
Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)
National Institutes of Health
Stay Updated
Get notified about new opportunities matching your interests.